Reference : Transcatheter left atrial appendage occlusion for stroke prevention in patients with ...
Scientific journals : Article
Human health sciences : Cardiovascular & respiratory systems
http://hdl.handle.net/2268/227154
Transcatheter left atrial appendage occlusion for stroke prevention in patients with atrial fibrillation: results from the Belgian registry.
English
Kefer, Joelle [> >]
Aminian, Adel [> >]
Vermeersch, Paul [> >]
de Potter, Tom [> >]
Stammen, Francis [> >]
Benit, Edouard [> >]
Budts, Werner [> >]
Missault, Luc [> >]
Drieghe, Benny [> >]
Buysschaert, Ian [> >]
Cornelis, Kristoff [> >]
Herzet, Jean-Manuel [> >]
Guedes, Antoine [> >]
Debbas, Nadia [> >]
Rivero, Maximo [> >]
LEMPEREUR, Mathieu mailto [Centre Hospitalier Universitaire de Liège - CHU > Département de médecine interne > Cardiologie interventionnelle >]
Lochy, Stijn [> >]
Casado-Arroyo, Ruben [> >]
Laruelle, Christophe [> >]
Debruyne, Philippe [> >]
Ledent, Thierry [> >]
2018
EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology
13
13
1603-1611
Yes
International
1774-024X
1969-6213
France
[en] AIMS: This study aimed to assess the safety and efficacy at midterm follow-up of left atrial appendage occlusion (LAAO) using different devices, in real life in Belgium. METHODS AND RESULTS: Between June 2009 and November 2016, 457 consecutive patients (63% male, 75+/-12 yrs, CHA2DS2-VASc 4+/-0.6, HAS-BLED 3.5+/-0.7) undergoing LAAO were included. Technical success was 97.1%. There were 19 periprocedural major adverse events (4.1%) including three deaths (0.6%), nine tamponades (1.9%), four major bleedings (0.8%) and two device embolisations (0.4%). Among patients successfully implanted having a complete follow-up (672 patient-years, median follow-up 370 days), the actual annual stroke rate was 1.2%, lower than the expected stroke risk of 4% (70% reduction). The observed bleeding rate was 2%, while the calculated risk was 3.7% (46% reduction). Kaplan-Meier analysis showed a similar overall survival (93+/-2% and 87+/-3% versus 91+/-3% and 87+/-4%; p=0.35) and event-free survival (92+/-2% and 84+/-3% versus 88+/-3% and 80+/-5%; p=0.17) at one and two years, for the ACP/Amulet versus the WATCHMAN groups of patients, respectively. CONCLUSIONS: The data from the Belgian left atrial appendage occlusion registry suggest that the procedure is effective and relatively safe in a real-world setting, using either the WATCHMAN or the ACP/Amulet device.
http://hdl.handle.net/2268/227154
10.4244/EIJ-D-17-00076

File(s) associated to this reference

Fulltext file(s):

FileCommentaryVersionSizeAccess
Restricted access
128th_issue-article_257.pdfPublisher postprint806.73 kBRequest copy

Bookmark and Share SFX Query

All documents in ORBi are protected by a user license.